ELL anticorps
Aperçu rapide pour ELL anticorps (ABIN7113778)
Antigène
Voir toutes ELL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- ELL antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- elongation factor RNA polymerase II
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Autre désignation
- ELL
-
Sujet
-
Synonyms: RNA polymerase II elongation factor ELL|Eleven-nineteen lysine-rich leukemia protein|ELL|C19orf17
Background: Elongation factor component of the super elongation complex(SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Elongation factor component of the little elongation complex(LEC), a complex required to regulate small nuclear RNA(snRNA) gene transcription by RNA polymerase II and III(PubMed:22195968, PubMed:23932780). Specifically required for stimulating the elongation step of RNA polymerase II-and III-dependent snRNA gene transcription(PubMed:23932780). ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation.
-
Poids moléculaire
- 68-80 kDa
-
ID gène
- 8178
-
UniProt
- P55199
Antigène
-